Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TLK286 and cisplatin in advanced NSCLC
NCT00077883Phase 2Completed
- Sponsor
- Telik, Inc.
- Start
- Feb 2004
- Primary completion
- Mar 2007
- Modality
- DNA Intercalators/Alkylators, Peptides, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of canfosfamide in non-small cell lung cancer (NSCLC), sponsored by Telik, Inc.. Started Feb 2004; status: completed.
02
Drugs
canfosfamide
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00077883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00077883.